Twist Bioscience Corp (NAS:TWST)
$ 46.39 -0.69 (-1.47%) Market Cap: 2.72 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 85/100

Q2 2019 Twist Bioscience Corp Earnings Call Transcript

Apr 30, 2019 / 08:30PM GMT
Release Date Price: $23.66 (-14.71%)
Operator

Good day, ladies and gentlemen, and welcome to Twist Bioscience Fiscal 2019 Second Quarter Financial Results Conference Call. (Operator Instructions)

I would now like to turn the conference over to your host, Jim Thorburn, Chief Financial Officer. You may begin, sir.

Jim Thorburn
Twist Bioscience Corporation - CFO

All right, thank you, Nicole. Good afternoon, everyone, and thank you for joining us today for Twist Bioscience conference call to review our fiscal 2019 second quarter financial results and business progress. Please review the press release we issued earlier today, which is available at our website at www.twistbioscience.com.

With me on today's call is Dr. Emily Leproust, CEO and Co-Founder of Twist. Emily will begin with a review of overall progress on Twist business, and I will report on our financial milestones and operational performance. Then, Emily will discuss our upcoming milestones and directions. We will then open up the call for questions. As a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot